Research progress of arginine vasopressin V2 receptor antagonist tolvaptan in the treatment of cirrhotic ascites.
- Author:
Yang Yang HU
1
;
Xing ZHANG
1
;
Ya Dong WANG
1
;
Cai Yan ZHAO
1
Author Information
- Publication Type:Journal Article
- MeSH: Humans; Tolvaptan/therapeutic use*; Ascites/drug therapy*; Receptors, Vasopressin; Liver Cirrhosis/drug therapy*; Sodium
- From: Chinese Journal of Internal Medicine 2023;62(7):881-884
- CountryChina
- Language:Chinese
